Daewoong Pharmaceutical Attracts Individual Investors' Attention... Stock Price Up 3.86%...
Search frequency for Daewoong Pharmaceutical, recently known as a top pharmaceutical company manufacturing and selling medicines such as Urusa and Albis, has surged.
As of 10:31 AM on the 14th, Daewoong Pharmaceutical's stock price rose 3.86% from the previous day to 148,000 KRW, with a trading volume of 763,705 shares, which is 31.49% of the 5-day average trading volume.
On December 11th, Daewoong Pharmaceutical was a market topic with the headline "Three consecutive days of strength due to expectations for a COVID-19 treatment."
Hot Picks Today
![About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]](https://cwcontent.asiae.co.kr/asiaresize/93/2026051416263163580_1778743590.jpg)
About 100 Trillion Won at Stake... "Samsung Strike Is an Unprecedented Opportunity" as Prices Surge 20% [Taiwan Chip Column]
- "Heading for 2 Million Won": The Company the Securities Industry Says Not to Doubt [Weekend Money]
- "Envious of Korean Daily Life"...Foreign Tourists Line Up in Central Myeongdong from Early Morning [Reportage]
- "Anyone Who Visited the Room Salon, Come Forward"… Gangnam Police Station Launches Full Staff Investigation After New Scandal
- Did Samsung and SK hynix Rise Too Much?... Foreign Assets Grow Despite Selling [Weekend Money]
※Source: AI Investment Assistant AI Rassiro
※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
